HIV / AIDS

Webcasts

Explore >>

Success After Failure: Moving beyond First-line Therapy

Medical News

Explore >>

Risk Factors for TB in People Diagnosed with HIV, Reports UK Study

19 Sep, 2017

Switch to INSTI-based Regimen Linked to Weight Gain in Virological Suppressed...

11 Sep, 2017

Higher Incidence Rates of LTFU among HIV/TB Patients not Initiating ART

07 Sep, 2017

New Content

Explore>>

REALITY: Enhanced Antimicrobial Prophylaxis + ART Improves Survival in Advanced HIV...
Pre-exposure Chemoprophylaxis with Oral FTC–TDF Prevents HIV Acquisition in Men Who...
Highlights of the International Congress of Drug Therapy in HIV Infection - 2016...

Our Publications

Explore>>

Antiretroviral Therapy – Current Recommendations

Datasheet: Lopinavir and Ritonavir (40mg/10mg) Oral Pellets

Fast Facts: Lopinavir and Ritonavir (40 mg/10 mg) Oral Pellets

Slide Library

Explore >>

HIV - Pre-exposure Prophylaxis (PrEP): Guidance on PrEP Use

HIV- Post-exposure Prophylaxis (PEP)

Isoniazid Preventive Therapy in HIV Infection

Patient Education

Explore >>

Live Healthier, Live Longer

Living with Hope

Conference Proceedings

Explore >>

Highlights of the International Congress of Drug Therapy in HIV Infection - 2016

Highlights of the 21st International AIDS Conference (AIDS 2016)

Highlights of the 23rd Conference on Retroviruses and Opportunistic Infections...

Poll

The results of the START study document benefits of initiating ART early (CD4 > 500) in naïve patients. What would you recommend to your patients:

Initiate ART irrespective of CD4 counts

62% (8 votes)

Defer ART till CD4 counts drops to < 500 cells/mm3

23% (3 votes)

Defer ART till CD4 counts drops to < 350 cells/mm3

8% (1 vote)

None of the above

8% (1 vote)

Total votes: 13

Or log in with...

Login With:

Search form

You are here

Webcasts

Medical News

New Content

Our Publications

Slide Library

Patient Education

Conference Proceedings

Poll

Other Links